Abstract
1. Blood platelets from normal children and children with the trisomy 21 form of Down's syndrome (mongolism) were studied to determine the cause of the well established reduction in platelet 5-HT in the disease.
2. Concentrations of endogenous 5-HT in the platelets from mongols were 25·3% of the concentrations found in normal children.
3. The net accumulation of 5-HT in the mongol cells was decreased to 52·7% of normal. This reduction was probably due, in part, to a defect in 5-HT transport, because the initial rates of 5-HT uptake at plasma concentrations of 10-6 and 10-5 M were significantly slower.
4. Experiments on the efflux of 5-HT from mongol platelets loaded with amine showed that the rate of loss was initially 2·6 and later 7·8 times faster than normal.
5. Platelet ATP in mongol cells was 26% of normal, and the reduction of ATP and 5-HT was in the molar ratio of 3:1.
6. It is considered that the low platelet 5-HT in Down's syndrome is due to a defective 5-HT transport mechanism and impaired 5-HT binding, resulting from a reduction in the essential binding substance, ATP.
Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- BOGDANSKI D. F., PLETSCHER A., BRODIE B. B., UNDENFRIEND S. Identification and assay of serotonin in brain. J Pharmacol Exp Ther. 1956 May;117(1):82–88. [PubMed] [Google Scholar]
- BORN G. V., INGRAM G. I., STACEY R. S. The relationship between 5-hydroxytryptamine and adenosine triphosphate in blood platelets. Br J Pharmacol Chemother. 1958 Mar;13(1):62–64. doi: 10.1111/j.1476-5381.1958.tb00191.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bazelon M., Paine R. S., Coeiw V. A., Hunt P., Houck J. C., Mahanand D. Reversal of hypotonia in infants with Down's syndrome by administration of 5-hydroxytryptophan. Lancet. 1967 May 27;1(7500):1130–1133. doi: 10.1016/s0140-6736(67)91708-4. [DOI] [PubMed] [Google Scholar]
- Berneis K. H., Da Prada M., Pletscher A. Micelle formation between 5-hydroxytryptamine and adenosine triphosphate in platelet storage organelles. Science. 1969 Aug 29;165(3896):913–914. doi: 10.1126/science.165.3896.913. [DOI] [PubMed] [Google Scholar]
- Boullin D. J., O'Brien R. A. The accumulation of guanethidine by human blood platelets. Br J Pharmacol. 1969 Jan;35(1):90–102. doi: 10.1111/j.1476-5381.1969.tb07969.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Da Prada M., Pletscher A. Isolated 5-hydroxytryptamine organelles of rabbit blood platelets: physiological properties and drug-induced changes. Br J Pharmacol. 1968 Nov;34(3):591–597. doi: 10.1111/j.1476-5381.1968.tb08487.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Davis R. B., White J. G. Localization of 5-hydroxytryptamine in blood platelets: an autoradiographic and ultrastructural study. Br J Haematol. 1968 Jul;15(1):93–99. doi: 10.1111/j.1365-2141.1968.tb01515.x. [DOI] [PubMed] [Google Scholar]
- HARDISTY R. M., STACEY R. S. 5-Hydroxytryptamine in normal human platelets. J Physiol. 1955 Dec 29;130(3):711–720. doi: 10.1113/jphysiol.1955.sp005437. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Holmsen H., Day H. J., Storm E. Adenine nucleotide metabolism of blood platelets. VI. Subcellular localization of nucleotide pools with different functions in the platelet release reaction. Biochim Biophys Acta. 1969 Aug 20;186(2):254–266. doi: 10.1016/0005-2787(69)90003-3. [DOI] [PubMed] [Google Scholar]
- Holmsen H., Holmsen I., Bernhardsen A. Microdetermination of adenosine diphosphate and adenosine triphosphate in plasma with firefly luciferase system. Anal Biochem. 1966 Dec;17(3):456–473. doi: 10.1016/0003-2697(66)90181-3. [DOI] [PubMed] [Google Scholar]
- Ireland D. M. Effect of thrombin on the radioactive nucleotides of human washed platelets. Biochem J. 1967 Nov;105(2):857–867. doi: 10.1042/bj1050857. [DOI] [PMC free article] [PubMed] [Google Scholar]
- JEROME H., LEJEUNE J., TURPIN R. [Study of the urinary excretion of some tryptophan metabolites in mongoloid children]. C R Hebd Seances Acad Sci. 1960 Jul 18;251:474–476. [PubMed] [Google Scholar]
- Jérome H., Kamoun P. Anomalie de la captaion de la sérotonine par les plaquettes sanguines des sujets trisomiques 21. I. Etude des caractéristiques générales de la captation. Bull Soc Chim Biol (Paris) 1968;50(4):907–921. [PubMed] [Google Scholar]
- McCOoy E. E., Rostafinsky M. J., Fishburn C. The concentration of serotonin by platelets in Down's Syndrome. J Ment Defic Res. 1968 Mar;12(1):18–21. doi: 10.1111/j.1365-2788.1968.tb00238.x. [DOI] [PubMed] [Google Scholar]
- Mills D. C., Thomas D. P. Blood platelet nucleotides in man and other species. Nature. 1969 Jun 7;222(5197):991–992. doi: 10.1038/222991a0. [DOI] [PubMed] [Google Scholar]
- Pletscher A. Metabolism, transfer and storage of 5-hydroxytryptamine in blood platelets. Br J Pharmacol Chemother. 1968 Jan;32(1):1–16. doi: 10.1111/j.1476-5381.1968.tb00423.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- ROSNER F., ONG B. H., PAINE R. S., MAHANAND D. BLOOD-SEROTONIN ACTIVITY IN TRISOMIC AND TRANSLOCATION DOWN'S SYNDROME. Lancet. 1965 Jun 5;1(7397):1191–1193. doi: 10.1016/s0140-6736(65)92722-4. [DOI] [PubMed] [Google Scholar]
- Saxl O. Down's syndrome: new aspects. Acta Paediatr Acad Sci Hung. 1968;9(3):329–336. [PubMed] [Google Scholar]
- Stacey R. S. Action of adenosine diphosphate on human platelets. Experientia. 1968 Sep 15;24(9):908–908. doi: 10.1007/BF02138645. [DOI] [PubMed] [Google Scholar]
- TOH C. C. Release of 5-hydroxytryptamine (serotonin) from the dog's gastrointestinal tract. J Physiol. 1954 Nov 29;126(2):248–254. doi: 10.1113/jphysiol.1954.sp005206. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tu J. B., Zellweger H. Blood-serotonin deficiency in Down's syndrome. Lancet. 1965 Oct 9;2(7415):715–716. doi: 10.1016/s0140-6736(65)90454-x. [DOI] [PubMed] [Google Scholar]